ALK-ngative Anaplastic large cell lymphoma(ALCL), Angioimmunoblastic T-cell lymphoma(AITL), Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS)
Conditions
Interventions
The schedules of LEED therapy and the following ASCT were defined. Other supportive therapies were not defined. The conditioning regimen LEED consisted of CPA(60mg/kg once daily from day minus 4 and m
Sponsors
Tosei General Hospital Department of Hematology and Oncology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ECOG PS 0 to 2 Fitst time ASCT Completed autologous stem cell harvest CR or PR afer first line chemotherapy Resistration after written informed consent
Exclusion criteria
Exclusion criteria: Patients with uncontroled DM even by the usage of insulin Patients with uncontroled HT Patients with past histories of myocardial infarction, congestive heart failure, and unstable angina Patients with the Ejection Frction less than 50 percent Patients with active double cacer Patients with active infection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression free survival at 1 year after ASCT | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival at 2 years afer ASCT Overall response rate at day 100 after ASCT Adverse Events and treatment related mortality at day 100 afer ASCT engraftment ratio and hematopoetic recovery at day 50 after ASCT | — |
Countries
Japan
Contacts
Public ContactKotaro Miyao
Tosei General Hospital Hematology and Oncology
Outcome results
None listed